Loading patent…
AssigneeBoehringer Ingelheim International GmbH
InventorsHenri Doods, Klaus Rudolf, Wolfgang Eberlein, Wolfhard Engel, Mats Hammar, Anna-Clara Spetz
Estimating the term…
The invention relates to a method of treatment or prevention of hot flushes in men who underwent castration, e.g. due to androgen ablation treatment in prostate cancer therapy, comprising administration of an effective amount of a CGRP antagonist and/or of a CGRP release inhibitor to the patient, and to the use of said active compounds for the manufacture of a pharmaceutical composition intended to be used in this method.
A method of treatment or prevention of hot flushes in castrated men comprising administration of an effective amount of an active substance selected from the group consisting of:
A pharmaceutical composition for treatment or prevention of hot flushes in castrated men, comprising an active substance selected from CGRP antagonists and CGRP release inhibitors and, optionally, an active compound used in conventional therapy selected from the group consisting of:
Dependencies are inferred from the claim text.